Brad Guild on Arthritis Biomarkers and Starting a Proteomics Group | GenomeWeb

At A Glance

Name: Brad Guild

Position: Director, protein sciences, Millennium Pharmaceuticals, since July 2003.

Background: Director, discovery proteomics, Millennium Pharmaceuticals, 2002-03.

Director, protein biochemistry, Millennium Predictive Medicine, 1999-02.

Director, functional genomics and other positions, Genome Therapeutics, 1995-99.

Director, molecular biology, ImmunoGen, 1989-94.

Founding scientist and head of gene expression, Somatix, 1988-89.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.